Clupea harengus chromosome 25, Ch_v2.0.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Teleostei; Clupei; Clupeiformes; Clupeoidei; Clupeidae; Clupea.
REFSEQ INFORMATION: The reference sequence is identical to\nLR535881.1.\nAssembly name: Ch_v2.0.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the UPPSALA UNIVERISTY on\n2019/04/16. The original whole-genome shotgun project has the\naccession CAADHV000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Clupea harengus Annotation Release\n 102\nAnnotation Version :: 102\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
enhancer of polycomb homolog 1-like, transcript variant X2
enhancer of polycomb homolog 1-like, transcript variant X1
enhancer of polycomb homolog 1-like isoform X1
enhancer of polycomb homolog 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 1 homolog, transcript variant X5
NACHT, LRR and PYD domains-containing protein 1 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 1 homolog, transcript variant X3
NACHT, LRR and PYD domains-containing protein 1 homolog, transcript variant X2
NACHT, LRR and PYD domains-containing protein 1 homolog isoform X1
NACHT, LRR and PYD domains-containing protein 1 homolog isoform X2
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X1
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X3
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X2
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X4
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X5
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X6
ATP-dependent 6-phosphofructokinase, platelet type-like isoform X7
NACHT, LRR and PYD domains-containing protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cAMP-responsive element modulator-like, transcript variant X2
cAMP-responsive element modulator-like, transcript variant X4
cAMP-responsive element modulator-like, transcript variant X1
cAMP-responsive element modulator-like, transcript variant X3
cAMP-responsive element modulator-like isoform X2
cAMP-responsive element modulator-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
kirre like nephrin family adhesion molecule 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
cell adhesion molecule 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cell adhesion molecule 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
succinate dehydrogenase complex, subunit C, integral membrane protein, transcript variant X2
succinate dehydrogenase complex, subunit C, integral membrane protein, transcript variant X1
succinate dehydrogenase cytochrome b560 subunit, mitochondrial isoform X2
succinate dehydrogenase cytochrome b560 subunit, mitochondrial isoform X1
ATPase Na+/K+ transporting subunit alpha 2a
sodium/potassium-transporting ATPase subunit alpha-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 3, subunit F
eukaryotic translation initiation factor 3 subunit F
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1a
type I phosphatidylinositol 4,5-bisphosphate 4-phosphatase-A
junctional protein associated with coronary artery disease
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
NACHT, LRR and PYD domains-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 6-like, transcript variant X3
uncharacterized protein LOC105906475 isoform X1
NACHT, LRR and PYD domains-containing protein 6-like isoform X2
uncharacterized LOC116219469, transcript variant X3
uncharacterized LOC116219469, transcript variant X2
uncharacterized LOC116219469, transcript variant X4
uncharacterized LOC116219469, transcript variant X1
uncharacterized protein LOC116219469 isoform X2
uncharacterized protein LOC116219469 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105904240, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC105904240, transcript variant X2
uncharacterized LOC116219471, transcript variant X2
uncharacterized LOC116219471, transcript variant X1
uncharacterized protein LOC116219471 isoform X2
uncharacterized protein LOC116219471 isoform X1
NLR family CARD domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
phospholipid phosphatase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phospholipid phosphatase 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
theg spermatid protein, transcript variant X1
theg spermatid protein, transcript variant X2
zinc finger and SCAN domain-containing protein 2-like, transcript variant X1
zinc finger and SCAN domain-containing protein 2-like, transcript variant X2
zinc finger and SCAN domain-containing protein 2-like, transcript variant X3
zinc finger and SCAN domain-containing protein 2-like isoform X1
zinc finger and SCAN domain-containing protein 2-like isoform X2
zinc finger and SCAN domain-containing protein 2-like isoform X3
zinc finger protein interacting with ribonucleoprotein K-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 2-like, transcript variant X4
zinc finger and SCAN domain-containing protein 2-like, transcript variant X5
zinc finger and SCAN domain-containing protein 2-like isoform X4
zinc finger and SCAN domain-containing protein 2-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SH2 domain-containing adapter protein F, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SH2 domain-containing adapter protein F, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SH2 domain-containing adapter protein F, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
homeotic protein spalt-major-like, transcript variant X1
homeotic protein spalt-major-like, transcript variant X2
homeotic protein spalt-major-like isoform X1
homeotic protein spalt-major-like isoform X2
zinc finger protein 853-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 853-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 875-like, transcript variant X1
zinc finger protein 875-like, transcript variant X2
eukaryotic translation initiation factor 4E-1B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP-sensitive inward rectifier potassium channel 10-like
mixed lineage kinase domain-like protein, transcript variant X3
mixed lineage kinase domain-like protein, transcript variant X1
mixed lineage kinase domain-like protein, transcript variant X4
mixed lineage kinase domain-like protein, transcript variant X2
mixed lineage kinase domain-like protein isoform X1
mixed lineage kinase domain-like protein isoform X2
SLAM family member 7-like, transcript variant X2
SLAM family member 7-like, transcript variant X1
hydroxysteroid 11-beta-dehydrogenase 1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF126-like, transcript variant X2
E3 ubiquitin-protein ligase RNF126-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF126-like isoform X2
E3 ubiquitin-protein ligase RNF126-like isoform X1
SURP and G-patch domain-containing protein 1, transcript variant X3
SURP and G-patch domain-containing protein 1, transcript variant X2
SURP and G-patch domain-containing protein 1, transcript variant X1
SURP and G-patch domain-containing protein 1
serine/threonine-protein kinase STK11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase STK11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
serine/threonine-protein kinase STK11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase STK11-like
SURP and G-patch domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SURP and G-patch domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SURP and G-patch domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SURP and G-patch domain-containing protein 1-like
serine/threonine kinase 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine kinase 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cold-inducible RNA-binding protein, transcript variant X2
cold-inducible RNA-binding protein, transcript variant X3
cold-inducible RNA-binding protein, transcript variant X1
cold-inducible RNA-binding protein, transcript variant X4
cold-inducible RNA-binding protein, transcript variant X5
cold-inducible RNA-binding protein isoform X1
cold-inducible RNA-binding protein isoform X2
cold-inducible RNA-binding protein isoform X3
yjeF N-terminal domain-containing 3-like, transcript variant X2
yjeF N-terminal domain-containing 3-like, transcript variant X3
yjeF N-terminal domain-containing 3-like isoform X2
yjeF N-terminal domain-containing 3-like isoform X3
yjeF N-terminal domain-containing 3-like, transcript variant X1
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
transcriptional repressor p66-alpha-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcriptional repressor p66-alpha-like, transcript variant X1
transcriptional repressor p66-alpha-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transcriptional repressor p66-alpha-like isoform X2
transcriptional repressor p66-alpha-like isoform X3
transcriptional repressor p66-alpha-like isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00271
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC116219649, transcript variant X2
uncharacterized LOC116219649, transcript variant X1
uncharacterized LOC116219649, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
CD48 antigen-like, transcript variant X1
CD48 antigen-like, transcript variant X2
uncharacterized LOC116219644, transcript variant X2
uncharacterized LOC116219644, transcript variant X1
cAMP responsive element binding protein 3-like 3b, transcript variant X1
cAMP responsive element binding protein 3-like 3b, transcript variant X2
cyclic AMP-responsive element-binding protein 3-like protein 3-A isoform X1
cyclic AMP-responsive element-binding protein 3-like protein 3-A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
NAD-dependent protein deacetylase sirtuin-6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NAD-dependent protein deacetylase sirtuin-6
COORDINATES: nucleotide motif:Rfam:12.0:RF00377
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00096
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger E-box-binding homeobox 1-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger E-box-binding homeobox 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
dual specificity mitogen-activated protein kinase kinase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
NACHT, LRR and PYD domains-containing protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription factor E2-alpha
cytochrome b-c1 complex subunit 10-like, transcript variant X2
cytochrome b-c1 complex subunit 10-like, transcript variant X1
methyl-CpG-binding domain protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
methyl-CpG-binding domain protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
methyl-CpG-binding domain protein 3 isoform X1
methyl-CpG-binding domain protein 3 isoform X2
methyl-CpG-binding domain protein 3-like, transcript variant X2
methyl-CpG-binding domain protein 3-like, transcript variant X1
methyl-CpG-binding domain protein 3-like isoform X1
methyl-CpG-binding domain protein 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein unc-13 homolog A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
hereditary hemochromatosis protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
SLAM family member 9-like, transcript variant X2
SLAM family member 9-like, transcript variant X1
lymphocyte antigen 97, tandem duplicate 3
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X3
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X4
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X5
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X1
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X7
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X2
NACHT, LRR and PYD domains-containing protein 3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like isoform X1
NACHT, LRR and PYD domains-containing protein 3-like isoform X3
NACHT, LRR and PYD domains-containing protein 3-like isoform X5
NACHT, LRR and PYD domains-containing protein 3-like isoform X2
NACHT, LRR and PYD domains-containing protein 3-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Ig kappa chain V-III region PC 2485/PC 4039-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Ig kappa-b4 chain C region-like, transcript variant X1
Ig kappa-b4 chain C region-like isoform X1
ankyrin repeat and SOCS box containing 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3, transcript variant X2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3, transcript variant X1
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 isoform X1
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: RB1-inducible coiled-coil protein 1
ST18 C2H2C-type zinc finger transcription factor
suppression of tumorigenicity 18 protein
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein-L-isoaspartate O-methyltransferase domain-containing protein 1
syntrophin, gamma 1, transcript variant X2
syntrophin, gamma 1, transcript variant X1
syntrophin, gamma 1, transcript variant X3
syntrophin, gamma 1, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 6 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 6 bases in 4 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein SNAI2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X3
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 2 isoform X3
ubiquitin-conjugating enzyme E2 variant 2 isoform X1
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 2 isoform X2
minichromosome maintenance complex component 4, transcript variant X1
minichromosome maintenance complex component 4, transcript variant X2
microtubule-associated protein, RP/EB family, member 2, transcript variant X2
microtubule-associated protein, RP/EB family, member 2, transcript variant X1
microtubule-associated protein RP/EB family member 2 isoform X1
microtubule-associated protein RP/EB family member 2 isoform X2
dystrobrevin, alpha, transcript variant X4
dystrobrevin, alpha, transcript variant X1
dystrobrevin, alpha, transcript variant X7
dystrobrevin, alpha, transcript variant X3
dystrobrevin, alpha, transcript variant X5
dystrobrevin, alpha, transcript variant X6
dystrobrevin, alpha, transcript variant X2
coiled-coil domain-containing protein 178, transcript variant X2
coiled-coil domain-containing protein 178, transcript variant X1
coiled-coil domain-containing protein 178, transcript variant X3
coiled-coil domain-containing protein 178, transcript variant X4
coiled-coil domain-containing protein 178, transcript variant X5
coiled-coil domain-containing protein 178 isoform X1
coiled-coil domain-containing protein 178 isoform X2
coiled-coil domain-containing protein 178 isoform X3
coiled-coil domain-containing protein 178 isoform X4
p21-activated protein kinase-interacting protein 1-like
ATP-binding cassette, sub-family D (ALD), member 4, transcript variant X3
ATP-binding cassette, sub-family D (ALD), member 4, transcript variant X4
ATP-binding cassette sub-family D member 4 isoform X3
ATP-binding cassette, sub-family D (ALD), member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP-binding cassette, sub-family D (ALD), member 4, transcript variant X6
ATP-binding cassette, sub-family D (ALD), member 4, transcript variant X2
ATP-binding cassette, sub-family D (ALD), member 4, transcript variant X1
ATP-binding cassette sub-family D member 4 isoform X1
ATP-binding cassette sub-family D member 4 isoform X2
ATP-binding cassette sub-family D member 4 isoform X5
ATP-binding cassette sub-family D member 4 isoform X4
voltage-dependent R-type calcium channel subunit alpha-1E-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
phosphotriesterase related, transcript variant X1
phosphotriesterase related, transcript variant X2
fuzzy planar cell polarity protein, transcript variant X2
fuzzy planar cell polarity protein, transcript variant X1
sterile alpha motif domain-containing protein 13
guanine nucleotide binding protein (G protein), gamma 5
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
meiotic recombination protein REC8 homolog
fizzy/cell division cycle 20 related 1b, transcript variant X3
fizzy/cell division cycle 20 related 1b, transcript variant X2
fizzy/cell division cycle 20 related 1b, transcript variant X1
fizzy-related protein homolog isoform X1
fizzy/cell division cycle 20 related 1b, transcript variant X4
fizzy-related protein homolog isoform X2
zebrafish testis-expressed 38, transcript variant X1
zebrafish testis-expressed 38, transcript variant X2
zebrafish testis-expressed 38, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zebrafish testis-expressed 38 isoform X1
zebrafish testis-expressed 38 isoform X2
zebrafish testis-expressed 38 isoform X3
aldehyde dehydrogenase 9 family, member A1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
4-trimethylaminobutyraldehyde dehydrogenase B
CXXC motif containing zinc binding protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: CXXC motif containing zinc binding protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sterol carrier protein 2
phosphotriesterase-related protein, transcript variant X1
phosphotriesterase-related protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alanine aminotransferase 2-like, transcript variant X3
alanine aminotransferase 2-like, transcript variant X2
alanine aminotransferase 2-like, transcript variant X1
alanine aminotransferase 2-like isoform X1
alanine aminotransferase 2-like isoform X3
alanine aminotransferase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
HORMA domain-containing protein 1-like, transcript variant X1
HORMA domain-containing protein 1-like, transcript variant X2
HORMA domain-containing protein 1-like, transcript variant X3
HORMA domain-containing protein 1-like isoform X1
HORMA domain-containing protein 1-like isoform X2
HORMA domain-containing protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cilia- and flagella-associated protein 57-like
low-density lipoprotein receptor-related protein 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
KN motif and ankyrin repeat domain-containing protein 2-like, transcript variant X1
KN motif and ankyrin repeat domain-containing protein 2-like, transcript variant X4
KN motif and ankyrin repeat domain-containing protein 2-like, transcript variant X2
KN motif and ankyrin repeat domain-containing protein 2-like, transcript variant X3
KN motif and ankyrin repeat domain-containing protein 2-like isoform X2
KN motif and ankyrin repeat domain-containing protein 2-like isoform X3
KN motif and ankyrin repeat domain-containing protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 U-like, transcript variant X2
ubiquitin-conjugating enzyme E2 U-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cAMP-specific 3',5'-cyclic phosphodiesterase 4B-like
cAMP-specific 3',5'-cyclic phosphodiesterase 4B-like, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B-like isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B-like, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4B-like isoform X2
SH3-containing GRB2-like protein 3-interacting protein 1
dynein light chain Tctex-type family member 5
BCL6A transcription repressor b, transcript variant X1
BCL6A transcription repressor b, transcript variant X2
family with sequence similarity 78 member Ba
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
IMP U3 small nucleolar ribonucleoprotein 3
U3 small nucleolar ribonucleoprotein protein IMP3
SEC22 homolog B, vesicle trafficking protein a
uncharacterized protein LOC406337 homolog, transcript variant X2
uncharacterized protein LOC406337 homolog, transcript variant X1
uncharacterized protein LOC406337 homolog, transcript variant X4
uncharacterized protein LOC406337 homolog, transcript variant X3
uncharacterized protein C1orf21 homolog isoform X1
uncharacterized protein C1orf21 homolog isoform X2
TSEN15 tRNA splicing endonuclease subunit
tRNA-splicing endonuclease subunit Sen15
acyl-CoA-binding domain-containing protein 5-B
abl-interactor 1b, transcript variant X1
abl-interactor 1b, transcript variant X5
abl-interactor 1b, transcript variant X3
abl-interactor 1b, transcript variant X6
abl-interactor 1b, transcript variant X2
abl-interactor 1b, transcript variant X4
abl-interactor 1b, transcript variant X7
amyloid beta A4 precursor protein-binding family B member 1-interacting protein-like, transcript variant X2
amyloid beta A4 precursor protein-binding family B member 1-interacting protein-like, transcript variant X1
amyloid beta A4 precursor protein-binding family B member 1-interacting protein-like isoform X2
amyloid beta A4 precursor protein-binding family B member 1-interacting protein-like isoform X1
uncharacterized protein si:ch211-252f13.5
annexin A13, like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
annexin A13, like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphoribosyl transferase domain containing 1b
phosphoribosyltransferase domain-containing protein 1b
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: rho GTPase-activating protein 21
dipeptidyl aminopeptidase-like protein 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dipeptidyl aminopeptidase-like protein 6, transcript variant X4
dipeptidyl aminopeptidase-like protein 6, transcript variant X1
dipeptidyl aminopeptidase-like protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dipeptidyl aminopeptidase-like protein 6 isoform X3
dipeptidyl aminopeptidase-like protein 6 isoform X4
dipeptidyl aminopeptidase-like protein 6 isoform X1
dipeptidyl aminopeptidase-like protein 6 isoform X2
lysine (K)-specific methyltransferase 2Cb, transcript variant X1
lysine (K)-specific methyltransferase 2Cb, transcript variant X3
lysine (K)-specific methyltransferase 2Cb, transcript variant X2
lysine (K)-specific methyltransferase 2Cb, transcript variant X4
lysine (K)-specific methyltransferase 2Cb, transcript variant X5
lysine (K)-specific methyltransferase 2Cb, transcript variant X6
histone-lysine N-methyltransferase 2C isoform X1
histone-lysine N-methyltransferase 2C isoform X3
histone-lysine N-methyltransferase 2C isoform X2
histone-lysine N-methyltransferase 2C isoform X6
histone-lysine N-methyltransferase 2C isoform X4
histone-lysine N-methyltransferase 2C isoform X5
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5'-AMP-activated protein kinase subunit gamma-1-like isoform X3
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
5'-AMP-activated protein kinase subunit gamma-1-like isoform X1
5'-AMP-activated protein kinase subunit gamma-1-like isoform X2
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
5'-AMP-activated protein kinase subunit gamma-1-like isoform X4
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X7
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X6
5'-AMP-activated protein kinase subunit gamma-2-like, transcript variant X8
5'-AMP-activated protein kinase subunit gamma-2-like isoform X5
5'-AMP-activated protein kinase subunit gamma-2-like isoform X6
BCL2 apoptosis regulator b, transcript variant X2
BCL2 apoptosis regulator b, transcript variant X1
BCL2 apoptosis regulator b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
FGGY carbohydrate kinase domain containing, transcript variant X4
FGGY carbohydrate kinase domain containing, transcript variant X2
FGGY carbohydrate kinase domain containing, transcript variant X3
FGGY carbohydrate kinase domain containing, transcript variant X1
FGGY carbohydrate kinase domain containing, transcript variant X5
FGGY carbohydrate kinase domain-containing protein isoform X1
FGGY carbohydrate kinase domain-containing protein isoform X3
FGGY carbohydrate kinase domain-containing protein isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: peroxiredoxin-6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SUN domain-containing ossification factor-like, transcript variant X1
SUN domain-containing ossification factor-like, transcript variant X2
SUN domain-containing ossification factor-like, transcript variant X3
SUN domain-containing ossification factor-like isoform X1
SUN domain-containing ossification factor-like isoform X2
SUN domain-containing ossification factor-like isoform X3
Fas-activated serine/threonine kinase, transcript variant X1
Fas-activated serine/threonine kinase, transcript variant X2
Fas-activated serine/threonine kinase, transcript variant X3
transmembrane and ubiquitin-like domain containing 1
transmembrane and ubiquitin-like domain-containing protein 1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3a, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 isoform X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 isoform X3
ATP-binding cassette, sub-family F (GCN20), member 2a, transcript variant X2
ATP-binding cassette, sub-family F (GCN20), member 2a, transcript variant X1
ATP-binding cassette sub-family F member 2a
COORDINATES: nucleotide motif:Rfam:12.0:RF00578
Fas apoptotic inhibitory molecule 2a, transcript variant X1
Fas apoptotic inhibitory molecule 2a, transcript variant X2
tetratricopeptide repeat domain 19, transcript variant X1
tetratricopeptide repeat domain 19, transcript variant X2
tetratricopeptide repeat protein 19, mitochondrial isoform X1
tetratricopeptide repeat protein 19, mitochondrial isoform X2
solute carrier family 4 member 2a, transcript variant X1
solute carrier family 4 member 2a, transcript variant X2
upstream binding transcription factor, like, transcript variant X1
upstream binding transcription factor, like, transcript variant X5
upstream binding transcription factor, like, transcript variant X6
upstream binding transcription factor, like, transcript variant X3
upstream binding transcription factor, like, transcript variant X7
upstream binding transcription factor, like, transcript variant X8
upstream binding transcription factor, like, transcript variant X4
upstream binding transcription factor, like, transcript variant X9
upstream binding transcription factor, like, transcript variant X2
upstream binding transcription factor, like isoform X1
upstream binding transcription factor, like isoform X4
upstream binding transcription factor, like isoform X5
upstream binding transcription factor, like isoform X2
upstream binding transcription factor, like isoform X6
upstream binding transcription factor, like isoform X7
upstream binding transcription factor, like isoform X3
upstream binding transcription factor, like isoform X8
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1a, transcript variant X1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1a, transcript variant X3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1a, transcript variant X4
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1a isoform X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1a isoform X3
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1a isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1a isoform X4
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1a, transcript variant X5
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1a isoform X5
family with sequence similarity 49 member Ba
MYC proto-oncogene, bHLH transcription factor b
ANKH inorganic pyrophosphate transport regulator b, transcript variant X2
ANKH inorganic pyrophosphate transport regulator b, transcript variant X1
progressive ankylosis protein homolog B isoform X2
progressive ankylosis protein homolog B isoform X1
OTU deubiquitinase with linear linkage specificity b, transcript variant X1
OTU deubiquitinase with linear linkage specificity b, transcript variant X2
OTU deubiquitinase with linear linkage specificity b isoform X1
OTU deubiquitinase with linear linkage specificity b isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: mammalian ependymin-related protein 1
RAN binding protein 9, transcript variant X1
RAN binding protein 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: reticulophagy regulator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
RNA-binding Raly-like protein, transcript variant X1
RNA-binding Raly-like protein, transcript variant X2
RNA-binding Raly-like protein isoform X1
RNA-binding Raly-like protein isoform X2
leucine rich repeat and coiled-coil centrosomal protein 1, transcript variant X1
leucine rich repeat and coiled-coil centrosomal protein 1, transcript variant X2
leucine-rich repeat and coiled-coil domain-containing protein 1
atypical chemokine receptor 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
atypical chemokine receptor 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
atypical chemokine receptor 4 isoform X2
atypical chemokine receptor 4 isoform X1
myosin VIIA and Rab interacting protein a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MAM and LDL-receptor class A domain-containing protein 2
serine/threonine-protein kinase pim-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium channel, voltage-dependent, beta 2b, transcript variant X2
calcium channel, voltage-dependent, beta 2b, transcript variant X3
calcium channel, voltage-dependent, beta 2b, transcript variant X1
calcium channel, voltage-dependent, beta 2b, transcript variant X6
calcium channel, voltage-dependent, beta 2b, transcript variant X5
calcium channel, voltage-dependent, beta 2b, transcript variant X8
calcium channel, voltage-dependent, beta 2b, transcript variant X7
calcium channel, voltage-dependent, beta 2b, transcript variant X4
voltage-dependent L-type calcium channel subunit beta-2b isoform X6
voltage-dependent L-type calcium channel subunit beta-2b isoform X5
voltage-dependent L-type calcium channel subunit beta-2b isoform X2
voltage-dependent L-type calcium channel subunit beta-2b isoform X3
voltage-dependent L-type calcium channel subunit beta-2b isoform X1
voltage-dependent L-type calcium channel subunit beta-2b isoform X8
voltage-dependent L-type calcium channel subunit beta-2b isoform X7
voltage-dependent L-type calcium channel subunit beta-2b isoform X4
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1
YES proto-oncogene 1, Src family tyrosine kinase
clusterin-like 1 (retinal), transcript variant X1
clusterin-like 1 (retinal), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
phosphatidate phosphatase LPIN2 isoform X1
phosphatidate phosphatase LPIN2 isoform X2
myomesin 1a (skelemin), transcript variant X2
myomesin 1a (skelemin), transcript variant X4
myomesin 1a (skelemin), transcript variant X3
myomesin 1a (skelemin), transcript variant X1
propionyl-CoA carboxylase beta chain, mitochondrial
NCK adaptor protein 1a, transcript variant X1
NCK adaptor protein 1a, transcript variant X2
phosphodiesterase 4C, cAMP-specific a, transcript variant X2
phosphodiesterase 4C, cAMP-specific a, transcript variant X1
phosphodiesterase 4C, cAMP-specific a, transcript variant X3
phosphodiesterase 4C, cAMP-specific a, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X4
MPV17 mitochondrial inner membrane protein like 2, transcript variant X3
MPV17 mitochondrial inner membrane protein like 2, transcript variant X2
MPV17 mitochondrial inner membrane protein like 2, transcript variant X1
gamma-interferon-inducible lysosomal thiol reductase
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant X5
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant X1
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant X4
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant X3
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit beta isoform X2
phosphatidylinositol 3-kinase regulatory subunit beta isoform X1
microtubule associated serine/threonine kinase 3a, transcript variant X3
microtubule associated serine/threonine kinase 3a, transcript variant X1
microtubule associated serine/threonine kinase 3a, transcript variant X2
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule-associated serine/threonine-protein kinase 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
CREB regulated transcription coactivator 1a, transcript variant X1
CREB regulated transcription coactivator 1a, transcript variant X2
CREB regulated transcription coactivator 1a, transcript variant X3
CREB-regulated transcription coactivator 1 isoform X1
CREB-regulated transcription coactivator 1 isoform X2
CREB-regulated transcription coactivator 1 isoform X3
cofactor required for Sp1 transcriptional activation, subunit 7
mediator of RNA polymerase II transcription subunit 26
NADH-quinone oxidoreductase subunit B 2-like
potassium voltage-gated channel subfamily V member 2
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1a, transcript variant X5
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1a, transcript variant X1
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1a, transcript variant X3
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1a, transcript variant X2
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1a, transcript variant X4
small conductance calcium-activated potassium channel protein 1a isoform X1
small conductance calcium-activated potassium channel protein 1a isoform X3
small conductance calcium-activated potassium channel protein 1a isoform X2
small conductance calcium-activated potassium channel protein 1a isoform X4
small conductance calcium-activated potassium channel protein 1a isoform X5
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC105900460
nuclear receptor subfamily 2, group F, member 6a, transcript variant X2
nuclear receptor subfamily 2, group F, member 6a, transcript variant X1
nuclear receptor subfamily 2 group F member 6a isoform X2
nuclear receptor subfamily 2 group F member 6a isoform X1
plasmalemma vesicle associated protein a, transcript variant X1
plasmalemma vesicle associated protein a, transcript variant X2
plasmalemma vesicle associated protein a, transcript variant X3
plasmalemma vesicle associated protein a isoform X1
plasmalemma vesicle associated protein a isoform X2
plasmalemma vesicle associated protein a isoform X3
39S ribosomal protein L34, mitochondrial
tRNA selenocysteine 1 associated protein 1b, transcript variant X1
tRNA selenocysteine 1 associated protein 1b, transcript variant X2
tRNA selenocysteine 1-associated protein 1-like isoform X1
tRNA selenocysteine 1-associated protein 1-like isoform X2
fat storage inducing transmembrane protein 1, like
fat storage-inducing transmembrane protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 469 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 493 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel, subfamily H (eag-related), member 2a
potassium voltage-gated channel subfamily H member 2a
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: solute carrier family 12 member 7
transforming growth factor, beta receptor 1 a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Vesicular, overexpressed in cancer, prosurvival protein 1-like
cysteine/serine-rich nuclear protein 1-like
xin actin binding repeat containing 1, transcript variant X4
xin actin binding repeat containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
xin actin binding repeat containing 1, transcript variant X2
xin actin-binding repeat-containing protein 1 isoform X1
xin actin-binding repeat-containing protein 1 isoform X2
xin actin-binding repeat-containing protein 1 isoform X4
xin actin binding repeat containing 1, transcript variant X3
xin actin-binding repeat-containing protein 1 isoform X3
oxidative stress responsive kinase 1a, transcript variant X2
oxidative stress responsive kinase 1a, transcript variant X1
serine/threonine-protein kinase OSR1a isoform X1
serine/threonine-protein kinase OSR1a isoform X2
phospholipase C, delta 1b, transcript variant X1
phospholipase C, delta 1b, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1b isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1b isoform X2
phospholipase C, delta 1b, transcript variant X3
phospholipase C, delta 1b, transcript variant X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1b isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1b isoform X4
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like b isoform X2
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like b isoform X1
hedgehog acyltransferase like, a, transcript variant X1
hedgehog acyltransferase like, a isoform X1
hedgehog acyltransferase like, a, transcript variant X2
hedgehog acyltransferase like, a isoform X2
zinc finger and BTB domain containing 47a, transcript variant X2
zinc finger and BTB domain containing 47a, transcript variant X1
zinc finger and BTB domain-containing protein 47 isoform X2
zinc finger and BTB domain-containing protein 47 isoform X1
vasoactive intestinal peptide receptor 1a, transcript variant X2
vasoactive intestinal peptide receptor 1a, transcript variant X1
vasoactive intestinal polypeptide receptor isoform X1
vasoactive intestinal polypeptide receptor isoform X2
uncharacterized protein LOC556220 homolog, transcript variant X3
uncharacterized protein LOC556220 homolog, transcript variant X2
uncharacterized protein LOC556220 homolog, transcript variant X1
methionine-R-sulfoxide reductase B2, mitochondrial-like
DnaJ (Hsp40) homolog, subfamily C, member 1
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha b, transcript variant X2
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha b, transcript variant X1
phosphatidylinositol 5-phosphate 4-kinase type-2 alpha isoform X2
phosphatidylinositol 5-phosphate 4-kinase type-2 alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ras responsive element binding protein 1b, transcript variant X3
ras responsive element binding protein 1b, transcript variant X2
ras responsive element binding protein 1b, transcript variant X1
ras-responsive element-binding protein 1 isoform X2
ras-responsive element-binding protein 1 isoform X1
protein phosphatase 1 regulatory subunit 3G
ribonuclease P/MRP 40 subunit, transcript variant X1
ribonuclease P/MRP 40 subunit, transcript variant X2
ribonuclease P protein subunit p40 isoform X1
ribonuclease P protein subunit p40 isoform X2
inhibin subunit beta Ab, transcript variant X2
inhibin subunit beta Ab, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00581
potassium voltage-gated channel subfamily B member 2a
potassium voltage-gated channel subfamily B member 2
transient receptor potential cation channel, subfamily A, member 1a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily A member 1a
DnaJ heat shock protein family (Hsp40) member B6a, transcript variant X1
DnaJ heat shock protein family (Hsp40) member B6a, transcript variant X2
dnaJ homolog subfamily B member 6a isoform X1
dnaJ homolog subfamily B member 6a isoform X2
RNA binding motif protein 33b, transcript variant X2
RNA binding motif protein 33b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PAX interacting (with transcription-activation domain) protein 1
sickle tail protein, transcript variant X4
sickle tail protein, transcript variant X2
sickle tail protein, transcript variant X3
sickle tail protein, transcript variant X1
sickle tail protein, transcript variant X5
sickle tail protein, transcript variant X6
chromosome 25 C10orf67 homolog, transcript variant X3
chromosome 25 C10orf67 homolog, transcript variant X2
chromosome 25 C10orf67 homolog, transcript variant X1
chromosome 25 C10orf67 homolog, transcript variant X4
uncharacterized protein C10orf67 homolog, mitochondrial isoform X1
uncharacterized protein C10orf67 homolog, mitochondrial isoform X3
uncharacterized protein C10orf67 homolog, mitochondrial isoform X2
pancreas associated transcription factor 1a
pancreas transcription factor 1 subunit alpha
discs, large (Drosophila) homolog-associated protein 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
discs, large (Drosophila) homolog-associated protein 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
discs, large (Drosophila) homolog-associated protein 1a, transcript variant X1
disks large-associated protein 1 isoform X2
disks large-associated protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF31, transcript variant X4
E3 ubiquitin-protein ligase RNF31, transcript variant X1
E3 ubiquitin-protein ligase RNF31, transcript variant X2
E3 ubiquitin-protein ligase RNF31, transcript variant X3
E3 ubiquitin-protein ligase RNF31 isoform X1
E3 ubiquitin-protein ligase RNF31 isoform X2
E3 ubiquitin-protein ligase RNF31 isoform X3
trimethylguanosine synthase 1, transcript variant X1
trimethylguanosine synthase 1, transcript variant X2
LYN proto-oncogene, Src family tyrosine kinase, transcript variant X2
LYN proto-oncogene, Src family tyrosine kinase, transcript variant X1
zinc finger, SWIM-type containing 5, transcript variant X3
zinc finger, SWIM-type containing 5, transcript variant X1
zinc finger, SWIM-type containing 5, transcript variant X2
zinc finger SWIM domain-containing protein 5 isoform X3
zinc finger SWIM domain-containing protein 5 isoform X2
zinc finger SWIM domain-containing protein 5 isoform X1
ELOVL fatty acid elongase 8a, transcript variant X1
ELOVL fatty acid elongase 8a, transcript variant X2
uncharacterized protein LOC100151273 homolog
target of EGR1, exonuclease, transcript variant X2
target of EGR1, exonuclease, transcript variant X1
testis associated actin remodelling kinase 2, transcript variant X1
testis associated actin remodelling kinase 2, transcript variant X2
dual specificity testis-specific protein kinase 2
thioredoxin related transmembrane protein 3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized si:dkey-181m9.8, transcript variant X1
uncharacterized si:dkey-181m9.8, transcript variant X3
uncharacterized si:dkey-181m9.8, transcript variant X2
uncharacterized protein si:dkey-181m9.8 isoform X1
uncharacterized protein si:dkey-181m9.8 isoform X2
uncharacterized protein si:dkey-181m9.8 isoform X3
inositol monophosphatase 1, transcript variant X2
inositol monophosphatase 1, transcript variant X1
inositol monophosphatase 1-like, transcript variant X2
inositol monophosphatase 1-like, transcript variant X1
M-phase specific PLK1 interacting protein
M-phase-specific PLK1-interacting protein
cysteine-rich secretory protein LCCL domain containing 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
cysteine-rich secretory protein LCCL domain-containing 1b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fATP synthase c subunit lysine N-methyltransferase
membrane-associated ring finger (C3HC4) 6
ankyrin repeat domain-containing protein 33B
catenin (cadherin-associated protein), delta 2b, transcript variant X3
catenin (cadherin-associated protein), delta 2b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
catenin (cadherin-associated protein), delta 2b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
catenin (cadherin-associated protein), delta 2b, transcript variant X2
catenin (cadherin-associated protein), delta 2b, transcript variant X1
catenin (cadherin-associated protein), delta 2b, transcript variant X7
catenin (cadherin-associated protein), delta 2b, transcript variant X6
mesoderm induction early response 1b, transcriptional regulator, transcript variant X2
mesoderm induction early response 1b, transcriptional regulator, transcript variant X1
mesoderm induction early response protein 1b isoform X1
mesoderm induction early response protein 1b isoform X2
mesoderm induction early response 1b, transcriptional regulator, transcript variant X3
mesoderm induction early response protein 1b isoform X3
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter-like
SERPINE1 mRNA binding protein 1b, transcript variant X2
SERPINE1 mRNA binding protein 1b, transcript variant X1
plasminogen activator inhibitor 1 RNA-binding protein isoform X2
plasminogen activator inhibitor 1 RNA-binding protein isoform X1
leucine-rich repeat-containing protein 52, transcript variant X3
leucine-rich repeat-containing protein 52 isoform X3
leucine-rich repeat-containing protein 52, transcript variant X2
leucine-rich repeat-containing protein 52, transcript variant X1
leucine-rich repeat-containing protein 52 isoform X1
leucine-rich repeat-containing protein 52 isoform X2
zyg-11 family member, cell cycle regulator, like
intracisternal A particle-promoted polypeptide, transcript variant X2
intracisternal A particle-promoted polypeptide, transcript variant X1
guanylate kinase 1a, transcript variant X2
guanylate kinase 1a, transcript variant X3
guanylate kinase 1a, transcript variant X1
chromosome 25 C1orf35 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromosome 25 C1orf35 homolog, transcript variant X1
multiple myeloma tumor-associated protein 2
ADP-ribosylation factor 1, transcript variant X3
ADP-ribosylation factor 1, transcript variant X2
ADP-ribosylation factor 1, transcript variant X1
wingless-type MMTV integration site family, member 3A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
wingless-type MMTV integration site family, member 9A
synaptosome associated protein 47, transcript variant X1
synaptosome associated protein 47, transcript variant X2
synaptosome associated protein 47, transcript variant X3
synaptosomal-associated protein 47 isoform X2
synaptosomal-associated protein 47 isoform X3
synaptosomal-associated protein 47 isoform X1
2-oxoglutarate and iron-dependent oxygenase JMJD4
iron-sulfur cluster assembly factor IBA57
putative transferase CAF17 homolog, mitochondrial
gap junction protein gamma 2, transcript variant X1
gap junction protein gamma 2, transcript variant X2
5-beta-cholestane-3-alpha,7-alpha-diol 12-alpha-hydroxylase
HIG1 hypoxia inducible domain family, member 1A, transcript variant X3
HIG1 hypoxia inducible domain family, member 1A, transcript variant X2
HIG1 domain family member 1A, mitochondrial isoform X2
HIG1 hypoxia inducible domain family, member 1A, transcript variant X1
HIG1 domain family member 1A, mitochondrial isoform X1
HIG1 domain family member 1A, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 13
transmembrane inner ear, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
transmembrane inner ear, transcript variant X1
transmembrane inner ear expressed protein isoform X2
transmembrane inner ear expressed protein isoform X1
parathyroid hormone 1 receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
parathyroid hormone 1 receptor, transcript variant X2
parathyroid hormone 1 receptor, transcript variant X1
parathyroid hormone/parathyroid hormone-related peptide receptor
corticotropin-releasing factor receptor 2, transcript variant X2
corticotropin-releasing factor receptor 2, transcript variant X1
corticotropin-releasing factor receptor 2, transcript variant X3
corticotropin-releasing factor receptor 2 isoform X2
corticotropin-releasing factor receptor 2 isoform X1
corticotropin-releasing factor receptor 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
ubiquitin carboxyl-terminal hydrolase 14
Rho-associated, coiled-coil containing protein kinase 1
GREB1 like retinoic acid receptor coactivator, transcript variant X3
GREB1 like retinoic acid receptor coactivator, transcript variant X4
GREB1 like retinoic acid receptor coactivator, transcript variant X1
GREB1 like retinoic acid receptor coactivator, transcript variant X2
abhydrolase domain containing 3, phospholipase
MIB E3 ubiquitin protein ligase 1, transcript variant X1
MIB E3 ubiquitin protein ligase 1, transcript variant X3
MIB E3 ubiquitin protein ligase 1, transcript variant X4
MIB E3 ubiquitin protein ligase 1, transcript variant X2
E3 ubiquitin-protein ligase mib1 isoform X1
E3 ubiquitin-protein ligase mib1 isoform X2
E3 ubiquitin-protein ligase mib1 isoform X3
GATA binding protein 6, transcript variant X2
GATA binding protein 6, transcript variant X1
Cdk5 and Abl enzyme substrate 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Cdk5 and Abl enzyme substrate 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CDK5 and ABL1 enzyme substrate 1 isoform X1
CDK5 and ABL1 enzyme substrate 1 isoform X2
NPC intracellular cholesterol transporter 1
uncharacterized LOC116219541, transcript variant X2
uncharacterized LOC116219541, transcript variant X1
epidermal growth factor receptor a (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
matrix metallopeptidase 16b (membrane-inserted)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
tetratricopeptide repeat protein 39C-like
uncharacterized LOC105900504, transcript variant X1
uncharacterized LOC105900504, transcript variant X2
uncharacterized LOC105900504, transcript variant X3
uncharacterized protein LOC105900504 isoform X1
uncharacterized protein LOC105900504 isoform X2
oxysterol-binding protein-related protein 1-like, transcript variant X2
oxysterol-binding protein-related protein 1-like, transcript variant X1
oxysterol-binding protein-related protein 1-like isoform X2
oxysterol-binding protein-related protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 521, transcript variant X7
zinc finger protein 521, transcript variant X6
zinc finger protein 521, transcript variant X4
zinc finger protein 521, transcript variant X5
zinc finger protein 521, transcript variant X3
zinc finger protein 521, transcript variant X2
zinc finger protein 521, transcript variant X1
SS18 subunit of BAF chromatin remodeling complex, transcript variant X1
SS18 subunit of BAF chromatin remodeling complex, transcript variant X2
SS18 subunit of BAF chromatin remodeling complex, transcript variant X3
BTB/POZ domain-containing protein KCTD1, transcript variant X2
BTB/POZ domain-containing protein KCTD1, transcript variant X1
BTB/POZ domain-containing protein KCTD1 isoform X2
BTB/POZ domain-containing protein KCTD1 isoform X1
desmoglein-2-like, transcript variant X1
desmoglein-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized si:ch73-140j24.4, transcript variant X3
uncharacterized si:ch73-140j24.4, transcript variant X1
uncharacterized si:ch73-140j24.4, transcript variant X2
uncharacterized si:ch73-140j24.4, transcript variant X4
uncharacterized protein si:ch73-140j24.4 isoform X1
uncharacterized protein si:ch73-140j24.4 isoform X2
uncharacterized protein si:ch73-140j24.4 isoform X3
uncharacterized protein si:ch73-140j24.4 isoform X4
complement component 8, alpha polypeptide
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
afadin- and alpha-actinin-binding protein-like
insulin-like growth factor-binding protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
insulin-like growth factor binding protein 1b, transcript variant X1
insulin-like growth factor binding protein 1b, transcript variant X2
insulin-like growth factor-binding protein 1b isoform X2
insulin-like growth factor-binding protein 1b isoform X1
uncharacterized LOC116219661, transcript variant X2
uncharacterized LOC116219661, transcript variant X1
uncharacterized protein LOC116219661 isoform X2
uncharacterized protein LOC116219661 isoform X1
NAD-dependent protein deacylase sirtuin-5, mitochondrial-like, transcript variant X2
NAD-dependent protein deacylase sirtuin-5, mitochondrial-like, transcript variant X1
NAD-dependent protein deacylase sirtuin-5, mitochondrial-like, transcript variant X3
NAD-dependent protein deacylase sirtuin-5, mitochondrial-like, transcript variant X4
NAD-dependent protein deacylase sirtuin-5, mitochondrial-like
phosphatase and actin regulator 1, transcript variant X2
phosphatase and actin regulator 1 isoform X2
phosphatase and actin regulator 1, transcript variant X1
phosphatase and actin regulator 1 isoform X1
PH domain and leucine rich repeat protein phosphatase 1
PH domain leucine-rich repeat-containing protein phosphatase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X1
receptor (TNFRSF)-interacting serine-threonine kinase 1, like, transcript variant X2
receptor-interacting serine/threonine-protein kinase 1
dual specificity phosphatase 22b, transcript variant X1
dual specificity phosphatase 22b, transcript variant X2
dual specificity protein phosphatase 22-B isoform X1
dual specificity protein phosphatase 22-B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myosin light chain kinase family, member 4a
myosin light chain kinase family member 4
adhesion G protein-coupled receptor L2-like, transcript variant X1
adhesion G protein-coupled receptor L2-like, transcript variant X5
adhesion G protein-coupled receptor L2-like, transcript variant X3
adhesion G protein-coupled receptor L2-like, transcript variant X2
adhesion G protein-coupled receptor L2-like, transcript variant X10
adhesion G protein-coupled receptor L2-like, transcript variant X4
adhesion G protein-coupled receptor L2-like, transcript variant X6
adhesion G protein-coupled receptor L2-like, transcript variant X7
adhesion G protein-coupled receptor L2-like, transcript variant X9
adhesion G protein-coupled receptor L2-like, transcript variant X8
adhesion G protein-coupled receptor L2-like isoform X1
adhesion G protein-coupled receptor L2-like isoform X5
adhesion G protein-coupled receptor L2-like isoform X3
adhesion G protein-coupled receptor L2-like isoform X6
adhesion G protein-coupled receptor L2-like isoform X2
adhesion G protein-coupled receptor L2-like isoform X9
adhesion G protein-coupled receptor L2-like isoform X4
adhesion G protein-coupled receptor L2-like isoform X7
adhesion G protein-coupled receptor L2-like isoform X8
protein kinase, cAMP-dependent, catalytic, beta b, transcript variant X2
protein kinase, cAMP-dependent, catalytic, beta b, transcript variant X4
protein kinase, cAMP-dependent, catalytic, beta b, transcript variant X3
protein kinase, cAMP-dependent, catalytic, beta b isoform X2
protein kinase, cAMP-dependent, catalytic, beta b isoform X3
protein kinase, cAMP-dependent, catalytic, beta b isoform X4
protein kinase, cAMP-dependent, catalytic, beta b, transcript variant X1
protein kinase, cAMP-dependent, catalytic, beta b isoform X1
glycosylphosphatidylinositol anchor attachment 1
glycosylphosphatidylinositol anchor attachment 1 protein
SHANK-associated RH domain interacting protein, transcript variant X2
SHANK-associated RH domain interacting protein, transcript variant X1
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X2
ranBP-type and C3HC4-type zinc finger-containing protein 1 isoform X1
poly-U binding splicing factor a, transcript variant X7
poly-U binding splicing factor a, transcript variant X1
poly-U binding splicing factor a, transcript variant X4
poly-U binding splicing factor a, transcript variant X8
poly-U binding splicing factor a, transcript variant X5
poly-U binding splicing factor a, transcript variant X2
poly-U binding splicing factor a, transcript variant X3
poly-U binding splicing factor a, transcript variant X6
poly(U)-binding-splicing factor PUF60a isoform X4
poly(U)-binding-splicing factor PUF60a isoform X2
poly(U)-binding-splicing factor PUF60a isoform X3
poly(U)-binding-splicing factor PUF60a isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00191
ankyrin repeat domain-containing protein 13C-like
leucine zipper transcription factor-like 1
leucine zipper transcription factor-like protein 1
uncharacterized protein LOC563946 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
thread biopolymer filament subunit gamma
uncharacterized LOC116219536, transcript variant X1
uncharacterized LOC116219536, transcript variant X2
uncharacterized protein LOC116219536 isoform X1
uncharacterized protein LOC116219536 isoform X2
pre-mRNA processing factor 4Ba, transcript variant X2
pre-mRNA processing factor 4Ba, transcript variant X1
serine/threonine-protein kinase PRP4 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 220a, transcript variant X2
ring finger protein 220a, transcript variant X5
ring finger protein 220a, transcript variant X8
ring finger protein 220a, transcript variant X1
ring finger protein 220a, transcript variant X3
ring finger protein 220a, transcript variant X6
ring finger protein 220a, transcript variant X7
ring finger protein 220a, transcript variant X9
E3 ubiquitin-protein ligase RNF220 isoform X1
E3 ubiquitin-protein ligase RNF220 isoform X2
E3 ubiquitin-protein ligase RNF220 isoform X7
E3 ubiquitin-protein ligase RNF220 isoform X4
ring finger protein 220a, transcript variant X4
E3 ubiquitin-protein ligase RNF220 isoform X3
E3 ubiquitin-protein ligase RNF220 isoform X5
E3 ubiquitin-protein ligase RNF220 isoform X6
solute carrier family 6 member 9, transcript variant X3
solute carrier family 6 member 9, transcript variant X2
sodium- and chloride-dependent glycine transporter 1 isoform X2
solute carrier family 6 member 9, transcript variant X1
sodium- and chloride-dependent glycine transporter 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain-containing protein 24
uncharacterized protein LOC541359 homolog
von Willebrand factor C domain-containing protein 2-like
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, transcript variant X2
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
V-type proton ATPase 21 kDa proteolipid subunit
eukaryotic translation initiation factor 2B, subunit 3 gamma
translation initiation factor eIF-2B subunit gamma
calcyclin binding protein, transcript variant X1
calcyclin binding protein, transcript variant X2
28S ribosomal protein S14, mitochondrial
uncharacterized protein KIAA0040, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein KIAA0040, transcript variant X1
uncharacterized protein KIAA0040 homolog
tenascin R (restrictin, janusin), transcript variant X2
tenascin R (restrictin, janusin), transcript variant X3
tenascin R (restrictin, janusin), transcript variant X1
bone morphogenetic protein/retinoic acid inducible neural-specific 2
BMP/retinoic acid-inducible neural-specific protein 2
aspartyl-tRNA synthetase 2, mitochondrial
kelch-like family member 20, transcript variant X1
kelch-like family member 20, transcript variant X2
ankyrin repeat domain-containing protein 45
RAS protein activator like 2, transcript variant X5
RAS protein activator like 2, transcript variant X6
ras GTPase-activating protein nGAP isoform X5
ras GTPase-activating protein nGAP isoform X6
RAS protein activator like 2, transcript variant X7
RAS protein activator like 2, transcript variant X4
RAS protein activator like 2, transcript variant X3
RAS protein activator like 2, transcript variant X1
RAS protein activator like 2, transcript variant X2
ras GTPase-activating protein nGAP isoform X1
ras GTPase-activating protein nGAP isoform X4
ras GTPase-activating protein nGAP isoform X2
ras GTPase-activating protein nGAP isoform X3
ras GTPase-activating protein nGAP isoform X7
RAS protein activator like 2, transcript variant X8
ras GTPase-activating protein nGAP isoform X8
RAS protein activator like 2, transcript variant X9
ras GTPase-activating protein nGAP isoform X9
DEAH (Asp-Glu-Ala-His) box helicase 9, transcript variant X1
DEAH (Asp-Glu-Ala-His) box helicase 9, transcript variant X2
DEAH (Asp-Glu-Ala-His) box helicase 9, transcript variant X3
DEAH (Asp-Glu-Ala-His) box helicase 9, transcript variant X4
testicular spindle-associated protein SHCBP1L
laminin subunit gamma-2-like, transcript variant X1
laminin subunit gamma-2-like, transcript variant X2
nicotinamide nucleotide adenylyltransferase 2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2
SMG7 nonsense mediated mRNA decay factor, transcript variant X1
SMG7 nonsense mediated mRNA decay factor, transcript variant X3
SMG7 nonsense mediated mRNA decay factor, transcript variant X2
SMG7 nonsense mediated mRNA decay factor, transcript variant X4
uncharacterized LOC122128837, transcript variant X1
uncharacterized LOC122128837, transcript variant X2
uncharacterized LOC122128837, transcript variant X3
T cell receptor alpha variable 14/delta variable 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
T cell receptor alpha variable 38-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
maltase-glucoamylase, intestinal-like, transcript variant X2
maltase-glucoamylase, intestinal-like, transcript variant X1
uncharacterized LOC105894943, transcript variant X3
uncharacterized LOC105894943, transcript variant X2
uncharacterized LOC105894943, transcript variant X1
uncharacterized protein LOC105894943 isoform X3
uncharacterized protein LOC105894943 isoform X2
uncharacterized protein LOC105894943 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
T cell receptor alpha variable 36/delta variable 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
T-cell receptor alpha chain V region CTL-F3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
T cell receptor alpha variable 26-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
immunoglobulin lambda variable 2-14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments